Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -601,924 | -295,746 | -161,376 | -589,526 | -439,506 |
| Depreciation Amortization | 7,264 | 4,585 | 2,300 | 9,531 | 7,148 |
| Accounts receivable | 14,842 | 8,240 | 14,638 | -15,367 | 1,039 |
| Accounts payable and accrued liabilities | 2,972 | -3,626 | -4,576 | -4,483 | -10,388 |
| Other Working Capital | -33,783 | -56,314 | -5,203 | 35,664 | -6,050 |
| Other Operating Activity | 243,271 | 83,008 | 22,600 | 168,291 | 117,437 |
| Operating Cash Flow | $-367,358 | $-259,853 | $-131,617 | $-395,890 | $-330,320 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -5,000 | N/A | N/A |
| PPE Investments | -19,163 | -9,809 | -5,664 | -3,906 | -2,616 |
| Purchase Of Investment | -722,523 | -382,071 | -159,105 | -1,293,416 | -1,172,291 |
| Sale Of Investment | 829,544 | 550,717 | 275,725 | 744,225 | 510,947 |
| Investing Cash Flow | $87,858 | $158,837 | $105,956 | $-553,097 | $-663,960 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 729,460 | N/A | N/A | N/A | N/A |
| Debt Repayment | -410,791 | -5,582 | -2,884 | -9,618 | -6,704 |
| Common Stock Issued | N/A | N/A | 7,651 | 93,640 | N/A |
| Other Financing Activity | 95,084 | 88,869 | -13 | 846,589 | 934,931 |
| Financing Cash Flow | $413,753 | $83,287 | $4,754 | $930,611 | $928,227 |
| Exchange Rate Effect | -906 | -952 | -270 | 209 | -83 |
| Beginning Cash Position | 95,232 | 95,232 | 95,232 | 113,399 | 113,399 |
| End Cash Position | 228,579 | 76,551 | 74,055 | 95,232 | 47,263 |
| Net Cash Flow | $133,347 | $-18,681 | $-21,177 | $-18,167 | $-66,136 |
| Free Cash Flow | |||||
| Operating Cash Flow | -367,358 | -259,853 | -131,617 | -395,890 | -330,320 |
| Capital Expenditure | -19,163 | -9,809 | -5,664 | -3,906 | -2,616 |
| Free Cash Flow | -386,521 | -269,662 | -137,281 | -399,796 | -332,936 |